"" Australia's third vaccine option, Novavax, has been contracted for 51 million doses but is unlikely to be approved for use in Australia for several months as it is still undergoing phase three clinical trials in the United Kingdom."
Ann: COVID19 Vaccine Feasibility Assessment, page-580
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.40M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $7.845K | 66.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 173739 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 56838 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| IDT (ASX) Chart |